1
|
Melville CA, Hatton C, Beer E, Hastings RP, Cooper SA, McMeekin N, Dagnan D, Appleton K, Scott K, Fulton L, Jones RSP, McConnachie A, Zhang R, Knight R, Knowles D, Williams C, Briggs A, Jahoda A. Predictors and moderators of the response of adults with intellectual disabilities and depression to behavioural activation and guided self-help therapies. J Intellect Disabil Res 2023; 67:986-1002. [PMID: 37344986 DOI: 10.1111/jir.13063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 05/20/2023] [Accepted: 05/24/2023] [Indexed: 06/23/2023]
Abstract
BACKGROUND No previous studies have reported predictors and moderators of outcome of psychological therapies for depression experienced by adults with intellectual disabilities (IDs). We investigated baseline variables as outcome predictors and moderators based on a randomised controlled trial where behavioural activation was compared with guided self-help. METHODS This study was an exploratory secondary data analysis of data collected during a randomised clinical trial. Participants (n = 161) were randomised to behavioural activation or guided self-help and followed up for 12 months. Pre-treatment variables were included if they have previously been shown to be associated with an increased risk of having depression in adults with IDs or have been reported as a potential predictor or moderator of outcome of treatment for depression with psychological therapies. The primary outcome measure, the Glasgow Depression Scale for Adults with Learning Disabilities (GDS-LD), was used as the dependant variable in mixed effects regression analyses testing for predictors and moderators of outcome, with baseline GDS-LD, treatment group, study centre and antidepressant use as fixed effects, and therapist as a random effect. RESULTS Higher baseline anxiety (mean difference in outcome associated with a 1 point increase in anxiety 0.164, 95% confidence interval [CI] 0.031, 0.297; P = 0.016), lower performance intelligence quotient (IQ) (mean difference in outcome associated with a 1 point increase in IQ 0.145, 95% CI 0.009, 0.280; P = 0.037) and hearing impairment (mean difference 3.449, 95% CI 0.466, 6.432; P = 0.024) were predictors of poorer outcomes, whilst greater severity of depressive symptoms at baseline (mean difference in outcome associated with 1 point increase in depression -0.160, 95% CI -0.806, -0.414; P < 0.001), higher expectation of change (mean difference in outcome associated with a 1 point increase in expectation of change -1.013, 95% CI -1.711, -0.314; p 0.005) and greater percentage of therapy sessions attended (mean difference in outcome with 1 point increase in percentage of sessions attended -0.058, 95% CI -0.099, -0.016; P = 0.007) were predictors of more positive outcomes for treatment after adjusting for randomised group allocation. The final model included severity of depressive and anxiety symptoms, lower WASI performance IQ subscale, hearing impairment, higher expectation of change and percentage of therapy sessions attended and explained 35.3% of the variance in the total GDS-LD score at 12 months (R2 = 0.353, F4, 128 = 17.24, P < 0.001). There is no evidence that baseline variables had a moderating effect on outcome for treatment with behavioural activation or guided self-help. CONCLUSIONS Our results suggest that baseline variables may be useful predictors of outcomes of psychological therapies for adults with IDs. Further research is required to examine the value of these potential predictors. However, our findings suggest that therapists consider how baseline variables may enable them to tailor their therapeutic approach when using psychological therapies to treat depression experienced by adults with IDs.
Collapse
Affiliation(s)
- C A Melville
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - C Hatton
- Department of Social Care and Social Work, Manchester Metropolitan University, Manchester, UK
| | - E Beer
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - R P Hastings
- Centre for Educational Development, Appraisal and Research, University of Warwick, Coventry, UK
- Department of Psychiatry, Monash University, Melbourne, Australia
| | - S-A Cooper
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - N McMeekin
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - D Dagnan
- Clinical Psychology, Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust and University of Cumbria, Newcastle upon Tyne Tyne, UK
| | - K Appleton
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - K Scott
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - L Fulton
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - R S P Jones
- School of Psychology, Bangor University, Bangor, UK
| | - A McConnachie
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - R Zhang
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - R Knight
- Department of Social Care and Social Work, Manchester Metropolitan University, Manchester, UK
| | - D Knowles
- Centre for Educational Development, Appraisal and Research, University of Warwick, Coventry, UK
| | - C Williams
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| | - A Briggs
- Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
| | - A Jahoda
- Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
| |
Collapse
|
2
|
Aliberti R, Ambrosino F, Ammendola R, Angelucci B, Antonelli A, Anzivino G, Arcidiacono R, Bache T, Baeva A, Baigarashev D, Barbanera M, Bernhard J, Biagioni A, Bician L, Biino C, Bizzeti A, Blazek T, Bloch-Devaux B, Bonaiuto V, Boretto M, Bragadireanu AM, Britton D, Brizioli F, Brunetti MB, Bryman D, Bucci F, Capussela T, Carmignani J, Ceccucci A, Cenci P, Cerny V, Cerri C, Checcucci B, Conovaloff A, Cooper P, Cortina Gil E, Corvino M, Costantini F, Cotta Ramusino A, Coward D, D'Agostini G, Dainton JB, Dalpiaz P, Danielsson H, De Simone N, Di Filippo D, Di Lella L, Doble N, Duk V, Duval F, Döbrich B, Emelyanov D, Engelfried J, Enik T, Estrada-Tristan N, Falaleev V, Fantechi R, Fascianelli V, Federici L, Fedotov S, Filippi A, Fiorini M, Fry JR, Fu J, Fucci A, Fulton L, Gamberini E, Gatignon L, Georgiev G, Ghinescu SA, Gianoli A, Giorgi M, Giudici S, Gonnella F, Goudzovski E, Graham C, Guida R, Gushchin E, Hahn F, Heath H, Henshaw J, Holzer EB, Husek T, Hutanu OE, Hutchcroft D, Iacobuzio L, Iacopini E, Imbergamo E, Jenninger B, Jerhot J, Jones RWL, Kampf K, Kekelidze V, Kholodenko S, Khoriauli G, Khotyantsev A, Kleimenova A, Korotkova A, Koval M, Kozhuharov V, Kucerova Z, Kudenko Y, Kunze J, Kurochka V, Kurshetsov V, Lamanna G, Lanfranchi G, Lari E, Latino G, Laycock P, Lazzeroni C, Lehmann Miotto G, Lenti M, Leonardi E, Lichard P, Litov L, Lollini R, Lomidze D, Lonardo A, Lubrano P, Lupi M, Lurkin N, Madigozhin D, Mannelli I, Mapelli A, Marchetto F, Marchevski R, Martellotti S, Massarotti P, Massri K, Maurice E, Medvedeva M, Mefodev A, Menichetti E, Migliore E, Minucci E, Mirra M, Misheva M, Molokanova N, Moulson M, Movchan S, Napolitano M, Neri I, Newson F, Norton A, Noy M, Numao T, Obraztsov V, Ostankov A, Padolski S, Page R, Palladino V, Parenti A, Parkinson C, Pedreschi E, Pepe M, Perrin-Terrin M, Peruzzo L, Petrov P, Petrov Y, Petrucci F, Piandani R, Piccini M, Pinzino J, Polenkevich I, Pontisso L, Potrebenikov Y, Protopopescu D, Raggi M, Romano A, Rubin P, Ruggiero G, Ryjov V, Salamon A, Santoni C, Saracino G, Sargeni F, Schuchmann S, Semenov V, Sergi A, Shaikhiev A, Shkarovskiy S, Soldi D, Sozzi M, Spadaro T, Spinella F, Sturgess A, Sugonyaev V, Swallow J, Trilov S, Valente P, Velghe B, Venditti S, Vicini P, Volpe R, Vormstein M, Wahl H, Wanke R, Wrona B, Yushchenko O, Zamkovsky M, Zinchenko A. Search for Lepton Number and Flavor Violation in K^{+} and π^{0} Decays. Phys Rev Lett 2021; 127:131802. [PMID: 34623867 DOI: 10.1103/physrevlett.127.131802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/17/2021] [Accepted: 07/22/2021] [Indexed: 06/13/2023]
Abstract
Searches for the lepton number violating K^{+}→π^{-}μ^{+}e^{+} decay and the lepton flavor violating K^{+}→π^{+}μ^{-}e^{+} and π^{0}→μ^{-}e^{+} decays are reported using data collected by the NA62 experiment at CERN in 2017-2018. No evidence for these decays is found and upper limits of the branching ratios are obtained at 90% confidence level: B(K^{+}→π^{-}μ^{+}e^{+})<4.2×10^{-11}, B(K^{+}→π^{+}μ^{-}e^{+})<6.6×10^{-11} and B(π^{0}→μ^{-}e^{+})<3.2×10^{-10}. These results improve by 1 order of magnitude over previous results for these decay modes.
Collapse
Affiliation(s)
- R Aliberti
- Institut für Physik and PRISMA Cluster of Excellence, Universität Mainz, D-55099 Mainz, Germany
| | - F Ambrosino
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - R Ammendola
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - B Angelucci
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A Antonelli
- Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - G Anzivino
- Dipartimento di Fisica e Geologia dell'Università e INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - R Arcidiacono
- Dipartimento di Fisica dell'Università e INFN, Sezione di Torino, I-10125 Torino, Italy
| | - T Bache
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - A Baeva
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - D Baigarashev
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - M Barbanera
- INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - J Bernhard
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - A Biagioni
- INFN, Sezione di Roma I, I-00185 Roma, Italy
| | - L Bician
- Faculty of Mathematics, Physics and Informatics, Comenius University, 842 48 Bratislava, Slovakia
| | - C Biino
- INFN, Sezione di Torino, I-10125 Torino, Italy
| | - A Bizzeti
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Italy
| | - T Blazek
- Faculty of Mathematics, Physics and Informatics, Comenius University, 842 48 Bratislava, Slovakia
| | - B Bloch-Devaux
- Dipartimento di Fisica dell'Università e INFN, Sezione di Torino, I-10125 Torino, Italy
| | - V Bonaiuto
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - M Boretto
- Dipartimento di Fisica dell'Università e INFN, Sezione di Torino, I-10125 Torino, Italy
| | - A M Bragadireanu
- Horia Hulubei National Institute of Physics for R&D in Physics and Nuclear Engineering, 077125 Bucharest-Magurele, Romania
| | - D Britton
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - F Brizioli
- Dipartimento di Fisica e Geologia dell'Università e INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - M B Brunetti
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - D Bryman
- University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
| | - F Bucci
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Italy
| | - T Capussela
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - J Carmignani
- University of Lancaster, Lancaster LA1 4YW, United Kingdom
| | - A Ceccucci
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - P Cenci
- INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - V Cerny
- Faculty of Mathematics, Physics and Informatics, Comenius University, 842 48 Bratislava, Slovakia
| | - C Cerri
- INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - B Checcucci
- INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - A Conovaloff
- George Mason University, Fairfax, Virginia 22030, USA
| | - P Cooper
- George Mason University, Fairfax, Virginia 22030, USA
| | - E Cortina Gil
- Université Catholique de Louvain, B-1348 Louvain-La-Neuve, Belgium
| | - M Corvino
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - F Costantini
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | | | - D Coward
- George Mason University, Fairfax, Virginia 22030, USA
| | - G D'Agostini
- Dipartimento di Fisica, Sapienza Università di Roma e INFN, Sezione di Roma I, I-00185 Roma, Italy
| | - J B Dainton
- University of Lancaster, Lancaster LA1 4YW, United Kingdom
| | - P Dalpiaz
- Dipartimento di Fisica e Scienze della Terra dell'Università e INFN, Sezione di Ferrara, I-44122 Ferrara, Italy
| | - H Danielsson
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - N De Simone
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - D Di Filippo
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - L Di Lella
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - N Doble
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - V Duk
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - F Duval
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - B Döbrich
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - D Emelyanov
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - J Engelfried
- Instituto de Física, Universidad Autónoma de San Luis Potosí, 78240 San Luis Potosí, Mexico
| | - T Enik
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - N Estrada-Tristan
- Instituto de Física, Universidad Autónoma de San Luis Potosí, 78240 San Luis Potosí, Mexico
| | - V Falaleev
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - R Fantechi
- INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - V Fascianelli
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - L Federici
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - S Fedotov
- Institute for Nuclear Research of the Russian Academy of Sciences, 117312 Moscow, Russia
| | - A Filippi
- INFN, Sezione di Torino, I-10125 Torino, Italy
| | - M Fiorini
- Dipartimento di Fisica e Scienze della Terra dell'Università e INFN, Sezione di Ferrara, I-44122 Ferrara, Italy
| | - J R Fry
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - J Fu
- University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
| | - A Fucci
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - L Fulton
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - E Gamberini
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - L Gatignon
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - G Georgiev
- Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - S A Ghinescu
- Horia Hulubei National Institute of Physics for R&D in Physics and Nuclear Engineering, 077125 Bucharest-Magurele, Romania
| | - A Gianoli
- INFN, Sezione di Ferrara, I-44122 Ferrara, Italy
| | - M Giorgi
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - S Giudici
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - F Gonnella
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - E Goudzovski
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - C Graham
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - R Guida
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - E Gushchin
- Institute for Nuclear Research of the Russian Academy of Sciences, 117312 Moscow, Russia
| | - F Hahn
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - H Heath
- University of Bristol, Bristol BS8 1TH, United Kingdom
| | - J Henshaw
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - E B Holzer
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - T Husek
- Charles University, 116 36 Prague 1, Czech Republic
| | - O E Hutanu
- Horia Hulubei National Institute of Physics for R&D in Physics and Nuclear Engineering, 077125 Bucharest-Magurele, Romania
| | - D Hutchcroft
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - L Iacobuzio
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - E Iacopini
- Dipartimento di Fisica e Astronomia dell'Università e INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Italy
| | - E Imbergamo
- Dipartimento di Fisica e Geologia dell'Università e INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - B Jenninger
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - J Jerhot
- Charles University, 116 36 Prague 1, Czech Republic
| | - R W L Jones
- University of Lancaster, Lancaster LA1 4YW, United Kingdom
| | - K Kampf
- Charles University, 116 36 Prague 1, Czech Republic
| | - V Kekelidze
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - S Kholodenko
- Institute for High Energy Physics-State Research Center of Russian Federation, 142281 Protvino (MO), Russia
| | - G Khoriauli
- Institut für Physik and PRISMA Cluster of Excellence, Universität Mainz, D-55099 Mainz, Germany
| | - A Khotyantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, 117312 Moscow, Russia
| | - A Kleimenova
- Université Catholique de Louvain, B-1348 Louvain-La-Neuve, Belgium
| | - A Korotkova
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - M Koval
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - V Kozhuharov
- Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - Z Kucerova
- Faculty of Mathematics, Physics and Informatics, Comenius University, 842 48 Bratislava, Slovakia
| | - Y Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, 117312 Moscow, Russia
| | - J Kunze
- Institut für Physik and PRISMA Cluster of Excellence, Universität Mainz, D-55099 Mainz, Germany
| | - V Kurochka
- Institute for Nuclear Research of the Russian Academy of Sciences, 117312 Moscow, Russia
| | - V Kurshetsov
- Institute for High Energy Physics-State Research Center of Russian Federation, 142281 Protvino (MO), Russia
| | - G Lamanna
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - G Lanfranchi
- Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - E Lari
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - G Latino
- Dipartimento di Fisica e Astronomia dell'Università e INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Italy
| | - P Laycock
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - C Lazzeroni
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - G Lehmann Miotto
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - M Lenti
- Dipartimento di Fisica e Astronomia dell'Università e INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Italy
| | - E Leonardi
- INFN, Sezione di Roma I, I-00185 Roma, Italy
| | - P Lichard
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - L Litov
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - R Lollini
- Dipartimento di Fisica e Geologia dell'Università e INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - D Lomidze
- Institut für Physik and PRISMA Cluster of Excellence, Universität Mainz, D-55099 Mainz, Germany
| | - A Lonardo
- INFN, Sezione di Roma I, I-00185 Roma, Italy
| | - P Lubrano
- INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - M Lupi
- INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - N Lurkin
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - D Madigozhin
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - I Mannelli
- Scuola Normale Superiore e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - A Mapelli
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - F Marchetto
- INFN, Sezione di Torino, I-10125 Torino, Italy
| | - R Marchevski
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - S Martellotti
- Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - P Massarotti
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - K Massri
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - E Maurice
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - M Medvedeva
- Institute for Nuclear Research of the Russian Academy of Sciences, 117312 Moscow, Russia
| | - A Mefodev
- Institute for Nuclear Research of the Russian Academy of Sciences, 117312 Moscow, Russia
| | - E Menichetti
- Dipartimento di Fisica dell'Università e INFN, Sezione di Torino, I-10125 Torino, Italy
| | - E Migliore
- Dipartimento di Fisica dell'Università e INFN, Sezione di Torino, I-10125 Torino, Italy
| | - E Minucci
- Université Catholique de Louvain, B-1348 Louvain-La-Neuve, Belgium
| | - M Mirra
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - M Misheva
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - N Molokanova
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - M Moulson
- Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - S Movchan
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - M Napolitano
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - I Neri
- Dipartimento di Fisica e Scienze della Terra dell'Università e INFN, Sezione di Ferrara, I-44122 Ferrara, Italy
| | - F Newson
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - A Norton
- Dipartimento di Fisica e Scienze della Terra dell'Università e INFN, Sezione di Ferrara, I-44122 Ferrara, Italy
| | - M Noy
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - T Numao
- TRIUMF, Vancouver, British Columbia V6T 2A3, Canada
| | - V Obraztsov
- Institute for High Energy Physics-State Research Center of Russian Federation, 142281 Protvino (MO), Russia
| | - A Ostankov
- Institute for High Energy Physics-State Research Center of Russian Federation, 142281 Protvino (MO), Russia
| | - S Padolski
- Université Catholique de Louvain, B-1348 Louvain-La-Neuve, Belgium
| | - R Page
- University of Bristol, Bristol BS8 1TH, United Kingdom
| | - V Palladino
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - A Parenti
- Dipartimento di Fisica e Astronomia dell'Università e INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Italy
| | - C Parkinson
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - E Pedreschi
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - M Pepe
- INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - M Perrin-Terrin
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - L Peruzzo
- Institut für Physik and PRISMA Cluster of Excellence, Universität Mainz, D-55099 Mainz, Germany
| | - P Petrov
- Université Catholique de Louvain, B-1348 Louvain-La-Neuve, Belgium
| | - Y Petrov
- TRIUMF, Vancouver, British Columbia V6T 2A3, Canada
| | - F Petrucci
- Dipartimento di Fisica e Scienze della Terra dell'Università e INFN, Sezione di Ferrara, I-44122 Ferrara, Italy
| | - R Piandani
- Dipartimento di Fisica e Geologia dell'Università e INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - M Piccini
- INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - J Pinzino
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - I Polenkevich
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - L Pontisso
- INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - Yu Potrebenikov
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | | | - M Raggi
- Dipartimento di Fisica, Sapienza Università di Roma e INFN, Sezione di Roma I, I-00185 Roma, Italy
| | - A Romano
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - P Rubin
- George Mason University, Fairfax, Virginia 22030, USA
| | - G Ruggiero
- University of Lancaster, Lancaster LA1 4YW, United Kingdom
| | - V Ryjov
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - A Salamon
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - C Santoni
- Dipartimento di Fisica e Geologia dell'Università e INFN, Sezione di Perugia, I-06100 Perugia, Italy
| | - G Saracino
- Dipartimento di Fisica "Ettore Pancini" e INFN, Sezione di Napoli, I-80126 Napoli, Italy
| | - F Sargeni
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - S Schuchmann
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - V Semenov
- Institute for High Energy Physics-State Research Center of Russian Federation, 142281 Protvino (MO), Russia
| | - A Sergi
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - A Shaikhiev
- Université Catholique de Louvain, B-1348 Louvain-La-Neuve, Belgium
| | - S Shkarovskiy
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| | - D Soldi
- Dipartimento di Fisica dell'Università e INFN, Sezione di Torino, I-10125 Torino, Italy
| | - M Sozzi
- Dipartimento di Fisica dell'Università e INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - T Spadaro
- Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - F Spinella
- INFN, Sezione di Pisa, I-56100 Pisa, Italy
| | - A Sturgess
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - V Sugonyaev
- Institute for High Energy Physics-State Research Center of Russian Federation, 142281 Protvino (MO), Russia
| | - J Swallow
- University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - S Trilov
- University of Bristol, Bristol BS8 1TH, United Kingdom
| | - P Valente
- INFN, Sezione di Roma I, I-00185 Roma, Italy
| | - B Velghe
- TRIUMF, Vancouver, British Columbia V6T 2A3, Canada
| | - S Venditti
- CERN, European Organization for Nuclear Research, CH-1211 Geneva 23, Switzerland
| | - P Vicini
- INFN, Sezione di Roma I, I-00185 Roma, Italy
| | - R Volpe
- Université Catholique de Louvain, B-1348 Louvain-La-Neuve, Belgium
| | - M Vormstein
- Institut für Physik and PRISMA Cluster of Excellence, Universität Mainz, D-55099 Mainz, Germany
| | - H Wahl
- Dipartimento di Fisica e Scienze della Terra dell'Università e INFN, Sezione di Ferrara, I-44122 Ferrara, Italy
| | - R Wanke
- Institut für Physik and PRISMA Cluster of Excellence, Universität Mainz, D-55099 Mainz, Germany
| | - B Wrona
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - O Yushchenko
- Institute for High Energy Physics-State Research Center of Russian Federation, 142281 Protvino (MO), Russia
| | - M Zamkovsky
- Charles University, 116 36 Prague 1, Czech Republic
| | - A Zinchenko
- Joint Institute for Nuclear Research, 141980 Dubna (MO), Russia
| |
Collapse
|
3
|
Lamanna G, Aliberti R, Ambrosino F, Ammendola R, Angelucci B, Antonelli A, Anzivino G, Arcidiacono R, Barbanera M, Biagioni A, Bician L, Biino C, Bizzeti A, Blazek T, Bloch-Devaux B, Bonaiuto V, Boretto M, Bragadireanu M, Britton D, Brizioli F, Brunetti M, Bryman D, Bucci F, Capussela T, Ceccucci A, Cenci P, Cerny V, Cerri C, Checcucci B, Conovaloff A, Cooper P, Cortina Gil E, Corvino M, Costantini F, Cotta Ramusino A, Coward D, D’Agostini G, Dainton J, Dalpiaz P, Danielsson H, De Simone N, Di Filippo D, Di Lella L, Doble N, Dobrich B, Duval F, Duk V, Engelfried J, Enik T, Estrada-Tristan N, Falaleev V, Fantechi R, Fascianelli V, Federici L, Fedotov S, Filippi A, Fiorini M, Fry J, Fu J, Fucci A, Fulton L, Gamberini E, Gatignon L, Georgiev G, Ghinescu S, Gianoli A, Giorgi M, Giudici S, Gonnella F, Goudzovski E, Graham C, Guida R, Gushchin E, Hahn F, Heath H, Husek T, Hutanu O, Hutchcroft D, Iacobuzio L, Iacopini E, Imbergamo E, Jenninger B, Kampf K, Kekelidze V, Kholodenko S, Khoriauli G, Khotyantsev A, Kleimenova A, Korotkova A, Koval M, Kozhuharov V, Kucerova Z, Kudenko Y, Kunze J, Kurochka V, Kurshetsov V, Lanfranchi G, Lamanna G, Latino G, Laycock P, Lazzeroni C, Lenti M, Lehmann Miotto G, Leonardi E, Lichard P, Litov L, Lollini R, Lomidze D, Lonardo A, Lubrano P, Lupi M, Lurkin N, Madigozhin D, Mannelli I, Mannocchi G, Mapelli A, Marchetto F, Marchevski R, Martellotti S, Massarotti P, Massri K, Maurice E, Medvedeva M, Mefodev A, Menichetti E, Migliore E, Minucci E, Mirra M, Misheva M, Molokanova N, Moulson M, Movchan S, Napolitano M, Neri I, Newson F, Norton A, Noy M, Numao T, Obraztsov V, Ostankov A, Padolski S, Page R, Palladino V, Parkinson C, Pedreschi E, Pepe M, Perrin-Terrin M, Peruzzo L, Petrov P, Petrucci F, Piandani R, Piccini M, Pinzino J, Polenkevich I, Pontisso L, Potrebenikov Y, Protopopescu D, Raggi M, Romano A, Rubin P, Ruggiero G, Ryjov V, Salamon A, Santoni C, Saracino G, Sargeni F, Semenov V, Sergi A, Shaikhiev A, Shkarovskiy S, Soldi D, Sougonyaev V, Sozzi M, Spadaro T, Spinella F, Sturgess A, Swallow J, Trilov S, Valente P, Velghe B, Venditti S, Vicini P, Volpe R, Vormstein M, Wahl H, Wanke R, Wrona B, Yushchenko O, Zamkovsky M, Zinchenko A. NA62 and NA48/2 results on search for Heavy Neutral Leptons. EPJ Web Conf 2018. [DOI: 10.1051/epjconf/201817901009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
In this paper we present new results on upper limits for the search of Heavy Neutral Leptons (HNL) with data collected by NA48/2 (2003-2004), NA62-RK (2007) and NA62 (2015) CERN experiments. The data collected with different trigger configuration allow to search for both long and short living heavy neutrinos in the mass range below the kaon mass. In addition the status of the search for K+ → π+vv with the NA62 detector will be briefly presented.
Collapse
|
4
|
Sequist L, Gerber D, Fidias P, Shaw A, Temel J, Heist R, Gainor J, Fulton L, Kennedy E, Muzikansky A, Engelma J. Acquired Resistance to Afatinib in EGFR-Mutant Lung Cancer. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.08.229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
5
|
Piotrowska Z, Niederst M, Mino-Kenudson M, Morales-Oyarvide V, Fulton L, Lockerman E, Howe E, Gainor J, Fidias P, Heist R, Shaw A, Engelman J, Sequist L. Variation in Mechanisms of Acquired Resistance Among EGFR-Mutant NSCLC Patients With More Than 1 Postresistant Biopsy. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.08.032] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
6
|
Vail DM, von Euler H, Rusk AW, Barber L, Clifford C, Elmslie R, Fulton L, Hirschberger J, Klein M, London C, Martano M, McNiel EA, Morris JS, Northrup N, Phillips B, Polton G, Post G, Rosenberg M, Ruslander D, Sahora A, Siegel S, Thamm D, Westberg S, Winter J, Khanna C. A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs. J Vet Intern Med 2012; 26:598-607. [PMID: 22390318 PMCID: PMC3837094 DOI: 10.1111/j.1939-1676.2012.00897.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2011] [Revised: 01/04/2012] [Accepted: 01/23/2012] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND Effective treatments for dogs with advanced stage mast cell tumors (MCT) remain a pressing need. A micellar formulation of paclitaxel (paclitaxel [micellar]) has shown promise in early-phase studies. HYPOTHESIS/OBJECTIVES The objective was to demonstrate greater activity for paclitaxel (micellar) compared with lomustine. The null hypothesis was μ(p) = μ(L) (ie, proportion of responders for the paclitaxel [micellar] and lomustine groups, respectively). ANIMALS Two hundred and fifty-two dogs with advanced stage nonresectable grade 2 or 3 MCT. METHODS Prospective multicenter randomized double-blind positive-controlled clinical trial. The primary endpoint was confirmed overall response rate (CORR) at 14 weeks. A secondary endpoint, biologic observed response rate (BORR), also was calculated. Safety was assessed by the characterization and grading of adverse events (AE). RESULTS Overall CORR (7% versus 1%; P = .048) and BORR (23% versus 10%; P = .012) were greater for paclitaxel (micellar) compared with lomustine. Paclitaxel (micellar)-treated dogs were 6.5 times more likely to have a confirmed response and 3.1 times more likely to experience a biologic observed response. The majority of AE with paclitaxel (micellar) were transient and clinically manageable. Twenty-seven dogs (33%) receiving lomustine were discontinued because of hepatopathy compared with 3 dogs (2%) receiving paclitaxel (micellar) (P < .0001; odds ratio 26.7). CONCLUSIONS AND CLINICAL IMPORTANCE Paclitaxel (micellar)'s activity and safety profile are superior to lomustine. The addition of an active and novel taxane to the veterinary armamentarium could fill a substantial need and, as its mechanism of action and AE profile do not overlap with currently available TKI, its availability could lead to effective combination protocols.
Collapse
Affiliation(s)
- D M Vail
- Department of Medical Sciences, School of Veterinary Medicine and Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI 53706, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
London C, Mathie T, Stingle N, Clifford C, Haney S, Klein MK, Beaver L, Vickery K, Vail DM, Hershey B, Ettinger S, Vaughan A, Alvarez F, Hillman L, Kiselow M, Thamm D, Higginbotham ML, Gauthier M, Krick E, Phillips B, Ladue T, Jones P, Bryan J, Gill V, Novasad A, Fulton L, Carreras J, McNeill C, Henry C, Gillings S. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours. Vet Comp Oncol 2011; 10:194-205. [PMID: 22236194 DOI: 10.1111/j.1476-5829.2011.00275.x] [Citation(s) in RCA: 159] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The purpose of this study was to provide an initial assessment of the potential biologic activity of toceranib phosphate (Palladia®, Pfizer Animal Health, Madison, NJ, USA) in select solid tumours in dogs. Cases in which toceranib was used to treat dogs with apocrine gland anal sac adenocarcinoma (AGASACA), metastatic osteosarcoma (OSA), thyroid carcinoma, head and neck carcinoma and nasal carcinoma were included. Clinical benefit (CB) was observed in 63/85 (74%) dogs including 28/32 AGASACA [8 partial response (PR), 20 stable disease (SD)], 11/23 OSAs (1 PR and 10 SD), 12/15 thyroid carcinomas (4 PR and 8 SD), 7/8 head and neck carcinomas [1 complete response (CR), 5 PR and 1 SD] and 5/7 (1 CR and 4 SD) nasal carcinomas. For dogs experiencing CB, the median dose of toceranib was 2.8 mg kg(-1) , 36/63 (58.7%) were dosed on a Monday/Wednesday/Friday basis and 47/63 (74.6%) were treated 4 months or longer. Although these data provide preliminary evidence that toceranib exhibits CB in dogs with certain solid tumours, future prospective studies are necessary to define its true activity.
Collapse
Affiliation(s)
- C London
- Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Lawniczak MKN, Emrich SJ, Holloway AK, Regier AP, Olson M, White B, Redmond S, Fulton L, Appelbaum E, Godfrey J, Farmer C, Chinwalla A, Yang SP, Minx P, Nelson J, Kyung K, Walenz BP, Garcia-Hernandez E, Aguiar M, Viswanathan LD, Rogers YH, Strausberg RL, Saski CA, Lawson D, Collins FH, Kafatos FC, Christophides GK, Clifton SW, Kirkness EF, Besansky NJ. Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science 2010; 330:512-4. [PMID: 20966253 DOI: 10.1126/science.1195755] [Citation(s) in RCA: 223] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
The Afrotropical mosquito Anopheles gambiae sensu stricto, a major vector of malaria, is currently undergoing speciation into the M and S molecular forms. These forms have diverged in larval ecology and reproductive behavior through unknown genetic mechanisms, despite considerable levels of hybridization. Previous genome-wide scans using gene-based microarrays uncovered divergence between M and S that was largely confined to gene-poor pericentromeric regions, prompting a speciation-with-ongoing-gene-flow model that implicated only about 3% of the genome near centromeres in the speciation process. Here, based on the complete M and S genome sequences, we report widespread and heterogeneous genomic divergence inconsistent with appreciable levels of interform gene flow, suggesting a more advanced speciation process and greater challenges to identify genes critical to initiating that process.
Collapse
Affiliation(s)
- M K N Lawniczak
- Division of Cell and Molecular Biology, Imperial College London, South Kensington Campus, London SW7 2AZ, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Wilson RK, Ley TJ, Cole FS, Milbrandt JD, Clifton S, Fulton L, Fewell G, Minx P, Sun H, McLellan M, Pohl C, Mardis ER. Mutational profiling in the human genome. Cold Spring Harb Symp Quant Biol 2004; 68:23-9. [PMID: 15338599 DOI: 10.1101/sqb.2003.68.23] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
- R K Wilson
- Washington University School of Medicine, St. Louis, Missouri 63108, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Albuquerque K, Cirrone J, Aziz H, Har-El G, Sundaram K, Dipillo F, Fulton L, Aral I, Schulsinger A, Rotman M. Quality of life with functional pharyngeal preservation in advanced carcinomas of the base tongue complex using an integrated trimodality approach. Am J Clin Oncol 2001; 24:623-7. [PMID: 11801768 DOI: 10.1097/00000421-200112000-00020] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Standard management of advanced carcinoma arising from the base of the tongue or infiltrating that region from contiguous areas (henceforth referred to as base of tongue complex [BTC] tumors) with radical surgery and postoperative radiation therapy results in extensive loss of function affecting deglutition, speech, and physical appearance. From January 1995, 16 patients with advanced stage BTC tumors were entered in this phase II study. Eleven patients (74%) had N2-3 neck disease. To optimize neck control, those with clinical N+ nodes at presentation had neck dissection. This was followed by hyperfractionated radiotherapy at 120 cGy twice daily to a median dose of 7,320 cGy to the primary and 6,240 cGy to areas with pathologically positive nodes. Concomitant chemotherapy was administered during weeks 1 and 4 of the radiation therapy using bolus cisplatin 75 to 100 mg/m2 on day 1 and continuous infusional 5-fluorouracil 750 to 1,000 mg/m2/d from days 1 to 4 of each chemotherapy cycle. Survival curves were plotted for various events, using actuarial life table methods. A functional assessment was made at least 1 year after completion of treatment using a previously validated Head/Neck Performance Status Scale. The median follow-up period was 23 months. There was a 100% complete response to the treatment at the primary site. The actuarial 4-year local (primary site) control was 100%, locoregional control (including nodes) was 69%, and disease-specific survival was 70% at 4 years. The predominant acute toxicity (63% incidence) was reversible grade III mucositis resulting in a median of 9 days' interruption in treatment. All of the patients were able to complete the prescribed treatment course, and there were no treatment-related deaths. Quality of Life assessment after treatment examined all facets of oropharyngeal function. Of note, none of the patients required long-term tube feedings. For the nine patients who responded to the functional assessment questionnaire, the results were excellent (score >75). The mean score for ability to eat in public was 75, mean of 76 for normalcy of diet, and 91 for understandability of speech. Concomitant hyperfractionated chemoradiation therapy produced excellent functional preservation with good long-term control in this patient group with historically poor prognosis. A 4-year actuarial local control rate of 69% was obtained, which is comparable to results of radical surgery and adjuvant radiation therapy. Further studies with modifications of fractionation and use of newer chemotherapy agents/radioprotectors will improve on these gains while reducing toxicity.
Collapse
Affiliation(s)
- K Albuquerque
- Department of Radiation Oncology, Long Island College Hospital and State University of New York, Brooklyn, New York 11203, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Uusitalo M, Ibarra M, Fulton L, Kaplan M, Hoffman W, Lee C, Carter S, O'Brien J. Reconstruction with rectus abdominis myocutaneous free flap after orbital exenteration in children. Arch Ophthalmol 2001; 119:1705-9. [PMID: 11709024 DOI: 10.1001/archopht.119.11.1705] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
OBJECTIVE To present a 1-stage technique for orbital reconstruction after exenteration with the use of myocutaneous rectus abdominis free flap in children. SURGICAL TECHNIQUE After orbital exenteration, a myocutaneous rectus abdominis free flap with long vascular pedicle is harvested from the abdomen. The flap is transferred to the orbit and the vascular pedicle is passed through an opening made in the lateral orbital wall, where it is anastomosed to superficial temporal vessels. The skin of the flap is trimmed to correspond to the eyelid defect and the incisions are closed. METHODS After informed consent was obtained, 2 children, 3 and 8 years old, underwent orbital reconstruction with a rectus abdominis free flap after exenteration for orbital rhabdomyosarcoma and orbital osteosarcoma in the setting of retinoblastoma. RESULTS This technique allowed easy postoperative wound care. Viability of the flap was excellent. The technique provided sufficient volume to fill the orbit, with improved aesthetic results and minimal donor site deformity. CONCLUSIONS The postoperative care and aesthetic outcome in patients with rectus abdominis free flap after exenteration are much improved over those provided with traditional surgical techniques. This primary reconstruction is recommended for any patient requiring orbital exenteration, but particularly for pediatric patients who tolerate debridement of traditional exenteration sites poorly.
Collapse
Affiliation(s)
- M Uusitalo
- Department of Ophthalmology, University of California, San Francisco, 10 Kirkham St, Campus Box 0730, San Francisco, CA 94143-0730, USA
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Cliften PF, Hillier LW, Fulton L, Graves T, Miner T, Gish WR, Waterston RH, Johnston M. Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis. Genome Res 2001; 11:1175-86. [PMID: 11435399 DOI: 10.1101/gr.182901] [Citation(s) in RCA: 181] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Comparative sequence analysis has facilitated the discovery of protein coding genes and important functional sequences within proteins, but has been less useful for identifying functional sequence elements in nonprotein-coding DNA because the relatively rapid rate of change of nonprotein-coding sequences and the relative simplicity of non-coding regulatory sequence elements necessitates the comparison of sequences of relatively closely related species. We tested the use of comparative DNA sequence analysis to aid identification of promoter regulatory elements, nonprotein-coding RNA genes, and small protein-coding genes by surveying random DNA sequences of several Saccharomyces yeast species, with the goal of learning which species are best suited for comparisons with S. cerevisiae. We also determined the DNA sequence of a few specific promoters and RNA genes of several Saccharomyces species to determine the degree of conservation of known functional elements within the genome. Our results lead us to conclude that comparative DNA sequence analysis will enable identification of functionally conserved elements within the yeast genome, and suggest a path for obtaining this information.
Collapse
Affiliation(s)
- P F Cliften
- Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409:928-33. [PMID: 11237013 DOI: 10.1038/35057149] [Citation(s) in RCA: 1861] [Impact Index Per Article: 80.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
We describe a map of 1.42 million single nucleotide polymorphisms (SNPs) distributed throughout the human genome, providing an average density on available sequence of one SNP every 1.9 kilobases. These SNPs were primarily discovered by two projects: The SNP Consortium and the analysis of clone overlaps by the International Human Genome Sequencing Consortium. The map integrates all publicly available SNPs with described genes and other genomic features. We estimate that 60,000 SNPs fall within exon (coding and untranslated regions), and 85% of exons are within 5 kb of the nearest SNP. Nucleotide diversity varies greatly across the genome, in a manner broadly consistent with a standard population genetic model of human history. This high-density SNP map provides a public resource for defining haplotype variation across the genome, and should help to identify biomedically important genes for diagnosis and therapy.
Collapse
|
14
|
Hayden BH, Murray TG, Scott IU, Cicciarelli N, Hernandez E, Feuer W, Fulton L, O'Brien JM. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule. Arch Ophthalmol 2000; 118:1549-54. [PMID: 11074812 DOI: 10.1001/archopht.118.11.1549] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
OBJECTIVE To evaluate the impact of tumor burden and chemotherapy dose scheduling on the response to subconjunctival carboplatin treatment in a murine transgenic retinoblastoma model. METHODS Eighty simian virus 40 T antigen-positive mice were treated at age 5 or 10 weeks. Six control animals received placebo treatment. Twenty-four 5-week-old mice received 6 subconjunctival carboplatin injections at doses of 30 to 300 microg delivered at 72-hour intervals. Fifty 10-week-old mice received either 6 or 12 subconjunctival carboplatin injections at doses of 30 to 300 microg delivered at 72-hour intervals. All eyes were obtained at age 16 weeks for histopathologic examination. Eyes were graded as positive if any tumor was present. RESULTS All simian virus 40 T antigen-positive control eyes contained large tumor foci throughout the retina. Subconjunctival carboplatin injections controlled tumors in a dose-dependent manner. Tumor control was observed in 50% of treated eyes at 138.3 microg for the 10-week-old 6-injection group, 94.3 microg for the 5-week-old 6-injection group, and 85.9 microg for the 10-week-old 12-injection group. CONCLUSION Increased tumor burden requires an increase in subconjunctival carboplatin dose scheduling to maintain local tumor control in this murine model of retinoblastoma. CLINICAL RELEVANCE This study documents the efficacy of subconjunctival carboplatin in the treatment of an animal model of retinoblastoma. These data establish a framework for further human clinical trials. Arch Ophthalmol. 2000;118:1549-1554
Collapse
Affiliation(s)
- B H Hayden
- Bascom Palmer Eye Institute, Department of Opthalmology, University of Mialmi, PO Box 016880, Miami, FL 33101
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Abstract
PURPOSE To describe the clinical presentation of probable germ-line mosaicism in four retinoblastoma kindreds. METHODS Review of 255 retinoblastoma patients and their family records in a University of California, San Francisco-Bascom Palmer database to identify those with potential germ-line mosaicism. Parents and siblings of retinoblastoma patients were given comprehensive ophthalmologic examinations. RESULTS Four kindreds were identified, wherein retinoblastoma was diagnosed in two siblings and both parents demonstrated no evidence of retinoblastoma or retinocytoma. CONCLUSION Clinical appearance of germ-line mosaicism is demonstrated in our retinoblastoma patient populations. We recommend routine clinical screening of all parents and siblings of retinoblastoma patients to provide more accurate genetic counseling and to allow earlier examination and treatment of children at presymptomatic disease stages. Germ-line mosaicism must be considered as a genetic transmission pattern in these patients, and genetic counseling should specifically recognize this possibility. If a parent is germ-line mosaic, the possibility of bearing a second child with retinoblastoma is clearly higher than conventionally believed.
Collapse
Affiliation(s)
- J H Smith
- Department of Ophthalmology, University of California, San Francisco, CA 94143-0730, USA
| | | | | | | |
Collapse
|
16
|
Mayer K, Schüller C, Wambutt R, Murphy G, Volckaert G, Pohl T, Düsterhöft A, Stiekema W, Entian KD, Terryn N, Harris B, Ansorge W, Brandt P, Grivell L, Rieger M, Weichselgartner M, de Simone V, Obermaier B, Mache R, Müller M, Kreis M, Delseny M, Puigdomenech P, Watson M, Schmidtheini T, Reichert B, Portatelle D, Perez-Alonso M, Boutry M, Bancroft I, Vos P, Hoheisel J, Zimmermann W, Wedler H, Ridley P, Langham SA, McCullagh B, Bilham L, Robben J, Van der Schueren J, Grymonprez B, Chuang YJ, Vandenbussche F, Braeken M, Weltjens I, Voet M, Bastiaens I, Aert R, Defoor E, Weitzenegger T, Bothe G, Ramsperger U, Hilbert H, Braun M, Holzer E, Brandt A, Peters S, van Staveren M, Dirske W, Mooijman P, Klein Lankhorst R, Rose M, Hauf J, Kötter P, Berneiser S, Hempel S, Feldpausch M, Lamberth S, Van den Daele H, De Keyser A, Buysshaert C, Gielen J, Villarroel R, De Clercq R, Van Montagu M, Rogers J, Cronin A, Quail M, Bray-Allen S, Clark L, Doggett J, Hall S, Kay M, Lennard N, McLay K, Mayes R, Pettett A, Rajandream MA, Lyne M, Benes V, Rechmann S, Borkova D, Blöcker H, Scharfe M, Grimm M, Löhnert TH, Dose S, de Haan M, Maarse A, Schäfer M, Müller-Auer S, Gabel C, Fuchs M, Fartmann B, Granderath K, Dauner D, Herzl A, Neumann S, Argiriou A, Vitale D, Liguori R, Piravandi E, Massenet O, Quigley F, Clabauld G, Mündlein A, Felber R, Schnabl S, Hiller R, Schmidt W, Lecharny A, Aubourg S, Chefdor F, Cooke R, Berger C, Montfort A, Casacuberta E, Gibbons T, Weber N, Vandenbol M, Bargues M, Terol J, Torres A, Perez-Perez A, Purnelle B, Bent E, Johnson S, Tacon D, Jesse T, Heijnen L, Schwarz S, Scholler P, Heber S, Francs P, Bielke C, Frishman D, Haase D, Lemcke K, Mewes HW, Stocker S, Zaccaria P, Bevan M, Wilson RK, de la Bastide M, Habermann K, Parnell L, Dedhia N, Gnoj L, Schutz K, Huang E, Spiegel L, Sehkon M, Murray J, Sheet P, Cordes M, Abu-Threideh J, Stoneking T, Kalicki J, Graves T, Harmon G, Edwards J, Latreille P, Courtney L, Cloud J, Abbott A, Scott K, Johnson D, Minx P, Bentley D, Fulton B, Miller N, Greco T, Kemp K, Kramer J, Fulton L, Mardis E, Dante M, Pepin K, Hillier L, Nelson J, Spieth J, Ryan E, Andrews S, Geisel C, Layman D, Du H, Ali J, Berghoff A, Jones K, Drone K, Cotton M, Joshu C, Antonoiu B, Zidanic M, Strong C, Sun H, Lamar B, Yordan C, Ma P, Zhong J, Preston R, Vil D, Shekher M, Matero A, Shah R, Swaby IK, O'Shaughnessy A, Rodriguez M, Hoffmann J, Till S, Granat S, Shohdy N, Hasegawa A, Hameed A, Lodhi M, Johnson A, Chen E, Marra M, Martienssen R, McCombie WR. Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature 1999; 402:769-77. [PMID: 10617198 DOI: 10.1038/47134] [Citation(s) in RCA: 313] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The higher plant Arabidopsis thaliana (Arabidopsis) is an important model for identifying plant genes and determining their function. To assist biological investigations and to define chromosome structure, a coordinated effort to sequence the Arabidopsis genome was initiated in late 1996. Here we report one of the first milestones of this project, the sequence of chromosome 4. Analysis of 17.38 megabases of unique sequence, representing about 17% of the genome, reveals 3,744 protein coding genes, 81 transfer RNAs and numerous repeat elements. Heterochromatic regions surrounding the putative centromere, which has not yet been completely sequenced, are characterized by an increased frequency of a variety of repeats, new repeats, reduced recombination, lowered gene density and lowered gene expression. Roughly 60% of the predicted protein-coding genes have been functionally characterized on the basis of their homology to known genes. Many genes encode predicted proteins that are homologous to human and Caenorhabditis elegans proteins.
Collapse
Affiliation(s)
- K Mayer
- GSF-Forschungszentrum f. Umwelt u. Gesundheit, Munich Information Center for Protein Sequences am Max-Planck-Institut f. Biochemie, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Abstract
PURPOSE To report a case of spontaneous regression of orbital Langerhans cell granulomatosis. METHOD Case report. A 3-year-old girl was initially examined with a 5-week history of slowly progressive blepharoptosis and periorbital swelling of the left eye. RESULTS Computed tomographic scan showed a mass in the left orbit eroding into the left frontal bone; fine-needle aspiration confirmed diagnosis of Langerhans cell granulomatosis. After initial biopsy, the patient was treated by close observation alone. Six months after initial examination, the monostotic lesion had completely resolved. CONCLUSIONS In some cases of monostotic Langerhans cell granulomatosis, initial biopsy followed by observation alone may allow for the spontaneous regression of the lesion. This conservative approach to treatment is an important therapeutic option that may spare the patient the adverse effects of surgical resection, radiation, or chemotherapy.
Collapse
Affiliation(s)
- J H Smith
- Department of Ophthalmology, University of California, San Francisco 94143-0730, USA
| | | | | |
Collapse
|
18
|
Fulton L, Richards N. Creating the role of the retention program coordinator. Recruit Retent Restruct Rep 1995; 8:5-8. [PMID: 7648074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
During healthcare restructuring, nurse satisfaction can suffer. The following article describes how nurse executives and human resource professionals can implement a full- or part-time retention coordinator role for their healthcare facility. These authors describe how a retention coordinator can use formal and informal meetings to keep track of nurse satisfaction and develop strategies that identify and solve nurse satisfaction problems.
Collapse
|
19
|
Johnston M, Andrews S, Brinkman R, Cooper J, Ding H, Dover J, Du Z, Favello A, Fulton L, Gattung S. Complete nucleotide sequence of Saccharomyces cerevisiae chromosome VIII. Science 1994; 265:2077-82. [PMID: 8091229 DOI: 10.1126/science.8091229] [Citation(s) in RCA: 249] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The complete nucleotide sequence of Saccharomyces cerevisiae chromosome VIII reveals that it contains 269 predicted or known genes (300 base pairs or larger). Fifty-nine of these genes (22 percent) were previously identified. Of the 210 novel genes, 65 are predicted to encode proteins that are similar to other proteins of known or predicted function. Sixteen genes appear to be relatively recently duplicated. On average, there is one gene approximately every 2 kilobases. Although the coding density and base composition across the chromosome are not uniform, no regular pattern of variation is apparent.
Collapse
Affiliation(s)
- M Johnston
- Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Affiliation(s)
- L Fulton
- US Department of Agriculture, Human Nutrition Information Service, Hyattsville, MD 20782
| | | |
Collapse
|
21
|
Hogbin M, Fulton L. Eating quality of biscuits and pastry prepared at reduced fat levels. J Am Diet Assoc 1992; 92:993-5. [PMID: 1640048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- M Hogbin
- US Department of Agriculture, Human Nutrition Information Service, Hyattsville, MD 20782
| | | |
Collapse
|
22
|
Fulton L, Davis C. Roasting and braising beef roasts in microwave ovens. J Am Diet Assoc 1983; 83:560-3. [PMID: 6630817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Cooking time, yield, and palatability of beef round, chuck, and rib eye roasts cooked in microwave ovens and in conventional ovens were compared. Cooking times were considerably shorter in the microwave ovens than in the conventional ovens. Reduced power was used for microwave cooking of roasts, except that rib eye roasts were cooked at full power for the first 5 min. The yield of cooked lean meat was the same for round and chuck roasts cooked by either type of oven, while the yield was lower for rib eye roasts cooked in the microwave oven than for rib eye roasts cooked in conventional ovens. Tenderness, softness, and natural flavor panel ratings and tenderness as measured by shear force were not affected by the treatment. Rib eye roasts were browner and less juicy when cooked in the microwave ovens.
Collapse
|
23
|
Wittmann BK, Fulton L, Cooperberg PL, Lyons EA, Miller C, Shaw D. Molar pregnancy: early diagnosis by ultrasound. J Clin Ultrasound 1981; 9:153-156. [PMID: 6793633 DOI: 10.1002/jcu.1870090403] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
This report reviews four cases with vaginal bleeding and early ultrasound diagnosis of abnormal pregnancy before nine weeks gestation, who were followed by serial ultrasound examinations and subsequently diagnosed as hydatidiform mole. The findings support the view that hydatidiform mole may arise from a blighted ovum. It is concluded that vaginal bleeding in the first trimester should be investigated by diagnostic ultrasound, and the pregnancy by terminated if an abnormal development has been confirmed.
Collapse
|
24
|
Fulton L, Davis C. Baked products for the fat--controlled, low--cholesterol diet. J Am Diet Assoc 1978; 73:261-9. [PMID: 681648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Shortened cakes, sugar cookies, pastry, biscuits, muffins, and yeast bread were made with oil in place of hydrogenated shortening with little change in quality. Either 1 c. or 3/4 c. oil could be subsituted for hydrogenated shortening in shortened cakes, biscuits, muffins, and yeast bread. Sugar cookies were best when 1 c. oil replaced 1 c. hydrogenated shortening. Pastry was best when 3/4 c. oil was substituted for 1 c. shortening. The effect of method of mixing on product quality often was greater than the effect of the amount of oil.
Collapse
|
25
|
Fulton L, Davis C. Cooking chicken and turkey from the frozen and thawed states. J Am Diet Assoc 1974; 64:505-10. [PMID: 4856798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|